Population-Based Competing-Risk Analysis of Survival in Blastic Plasmacytoid Dendritic Cell Neoplasm Before and After CD123-Directed Tagraxofusp Therapy Approval Meeting Abstract (Web of Science)

cited authors

  • Ali, Manzer; Jehangir, Hanzala; Afzal, Waqas; Hadziahmetovic, Mersiha; Rashid, Hammad

publication date

  • September 1, 2025

webpage

published in

category

keywords

  • AML
  • SEER registry
  • blastic plasmacytoid dendritic cell neoplasm
  • survival analysis
  • tagraxofusp

volume

  • 25